Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmacoeconomics|October 13, 2010
An analysis of NICE's 'restricted' (or 'optimized') decisionsPhill O'Neill, Nancy J Devlin
Pharmacoeconomics|July 13, 2026
Optimisation or Restriction? Unpacking the Logic Behind NICE DecisionsNadine Henderson, Brittany Darrow, Phill O'Neill, et al.
Vaccine: X|May 17, 2021
Realising the broader value of vaccines in the UKSimon Brassel, Margherita Neri, Phill O'Neill, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 7, 2020
Does NICE influence the adoption and uptake of generics in the UK?Victoria Serra-Sastre, Simona Bianchi, Jorge Mestre-Ferrandiz, et al.
Pharmacoeconomics|September 17, 2013
Projecting expenditure on medicines in the UK NHSPhill O'Neill, Jorge Mestre-Ferrandiz, Ruth Puig-Peiro, et al.
Orphanet Journal of Rare Diseases|May 5, 2019
Comparing access to orphan medicinal products in EuropeBernarda Zamora, Francois Maignen, Phill O'Neill, et al.
Health Economics|September 25, 2014
The Influence of Cost-Effectiveness and Other Factors on Nice DecisionsHelen Dakin, Nancy Devlin, Yan Feng, et al.
Pageof 1